别名 Lotriga Granular、Omega-3 fatty acid ethyl esters、OMEGA-3-ACID ETHYL ESTERS + [18] 靶点 Lipid x Triglyceride 作用机制 脂质调节剂、甘油三酯调节剂 治疗领域 遗传病与畸形内分泌与代谢疾病其他疾病+ [2] 在研适应症 高脂血症I型高脂蛋白血症高甘油三酯血症+ [2] 非在研适应症 急性心肌梗塞颈动脉...
“Omega -3 Ethyl Esters”是一種特別的魚油脂類調節劑,美國食品藥品管理局(FDA)批准為飲食輔助藥物;以降低成年患者的甘油三酸脂(3 500 mg/dL)水準。每粒膠囊1200 mg,含有 430 mg EPA 和215 mg DHA;還含有1 mg Tocopherols。 用途(適應症):一般保健或用於降低高甘油三脂血症;有助預防心臟病發作及血管暢通...
Omega-3 fatty acids are long-chained, polyunsaturated fatty acids that appear to reduce the risk of coronary artery disease. Omega-3-acid ethylesters is the first prescription product containing omega-3 fatty acids. Omega-3 -acid ethylesters provide an additional option for reducing triglyceride ...
In general, omega-3 fatty acids did not affect C-reactive protein or interleukin-6 levels. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are absorbed following their oral administration as ethylesters to healthy volunteers and patients with hypertriglyceridaemia, with subsequent dose-...
中文别名:Omega-3-酸乙酯; 奥马科尔; 皮质瘤; 洛瓦萨; Omega-3 酸性乙酯 (USP); UNII-D87YGH4Z0Q; omega-3 脂肪酸乙酯; 脂肪酸、多元脂肪酸、omega-3 等酯类 英文名称:Omega-3-Acid Ethyl Esters 英文别名:Omega-3-acid Ethyl Esters; Omacor; Coromega; Lovaza; Omega-3 Acid Ethyl Esters (U...
GlaxoSmithKline.LOVAZA® (omega-3 acid ethyl esters) capsules, prescribing information. 2008. Appel LJ, Miller ER, 3rd, Seidler AJ, Whelton PK. Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of...
omega-3-acid ethyl esters are defined as the ethyl esters of alpha-linolenic acid, moroctic acid, eicosapentaenoic (timnodonic) acid, clupanodonic acid, and docosahexaenoic (cervonic) acid. The content of the total omega-3-acid ethyl esters is not less than 90 per cent. The content of ...
戊戌数据药品标准数据库提供了Omega-3-acid ethyl esters欧米加-3-酸乙酯欧洲药典标准的查询检索,包括Omega-3-acid ethyl esters欧米加-3-酸乙酯欧洲药典的版本EP4.0页码,以及药典的查询与下载.
戊戌数据药品标准数据库提供了Omega-3-Acid Ethyl Esters欧米加-3-酸乙酯美国药典标准的查询检索,包括Omega-3-Acid Ethyl Esters欧米加-3-酸乙酯美国药典的版本USP39-NF34页码,以及药典的查询与下载.
Omega 3Heart failureGISSI-PrevenzioneChronic heart failure, a syndrome of cardiac dysfunction associated with breathlessness, effort intolerance and fluid retention, affects 1-2% of the population. The most frequent cause is impairment of systolic function of the left ventricle, usually due to coronary...